Jul 4, 2024, 10:04
Ajay Major: ViPOR in LBCL of NEJM by Christopher Melani et al.
Ajay Major, Assistant Professor at the University of Colorado School of Medicine and Founder and President at Pager Publications, shared a post on X:
“ViPOR in LBCL NEJM by Christopher Melani et al.:
- 20 pts Ph1b / 40 Ph2; RP2D ven 800 mg
- ORR 54% overall: 62% (all CRs!) in non-GC, 67% (CR 53%) in DHL with BCL2
- 2-yr DOCR 78% w/o consolidation, post-CAR 2-yr PFS 30%
Great activity in high-risk R/R subtypes!”
Read further.
Source: Ajay Major/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 16:51
Nov 13, 2024, 16:49
Nov 13, 2024, 16:45
Nov 13, 2024, 16:25
Nov 13, 2024, 16:23
Nov 13, 2024, 16:08
Nov 13, 2024, 16:02
Nov 13, 2024, 15:56